260 related articles for article (PubMed ID: 18726787)
21. Association of chronic obstructive pulmonary disease and obstructive sleep apnea consequences.
Zamarrón C; García Paz V; Morete E; del Campo Matías F
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):671-82. PubMed ID: 19281082
[TBL] [Abstract][Full Text] [Related]
22. Effects of positive airway pressure therapy on cardiovascular and metabolic markers in males with obstructive sleep apnea.
Feliciano A; Oliveira MJ; Cysneiros A; Martinho C; Reis RP; Penque D; Pinto P; Bárbara C
Rev Port Pneumol (2006); 2017; 23(4):193-202. PubMed ID: 28596012
[TBL] [Abstract][Full Text] [Related]
23. [Obstructive sleep apnea syndrome(OSAS)and bone.].
Inoue D
Clin Calcium; 2016; 26(10):1399-1406. PubMed ID: 27666686
[TBL] [Abstract][Full Text] [Related]
24. Metabolic biomarkers in community obese children: effect of obstructive sleep apnea and its treatment.
Alonso-Álvarez ML; Terán-Santos J; Gonzalez Martinez M; Cordero-Guevara JA; Jurado-Luque MJ; Corral-Peñafiel J; Duran-Cantolla J; Ordax Carbajo E; MasaJimenez F; Kheirandish-Gozal L; Gozal D;
Sleep Med; 2017 Sep; 37():1-9. PubMed ID: 28899517
[TBL] [Abstract][Full Text] [Related]
25. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome.
Carneiro G; Togeiro SM; Hayashi LF; Ribeiro-Filho FF; Ribeiro AB; Tufik S; Zanella MT
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E380-4. PubMed ID: 18523125
[TBL] [Abstract][Full Text] [Related]
26. Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure.
Toraldo DM; De Benedetto M; Scoditti E; De Nuccio F
Sleep Breath; 2016 May; 20(2):457-65. PubMed ID: 26169715
[TBL] [Abstract][Full Text] [Related]
27. What Is the Prevalence of Symptomatic Obstructive Sleep Apnea Syndrome in Chronic Spinal Pain Patients? An Assessment of the Correlation of OSAS with Chronic Opioid Therapy, Obesity, and Smoking.
Pampati S; Manchikanti L
Pain Physician; 2016 May; 19(4):E569-79. PubMed ID: 27228523
[TBL] [Abstract][Full Text] [Related]
28. Concurrent presence of metabolic syndrome in obstructive sleep apnea syndrome exacerbates the cardiovascular risk: a sleep clinic cohort study.
Shiina K; Tomiyama H; Takata Y; Usui Y; Asano K; Hirayama Y; Nakamura T; Yamashina A
Hypertens Res; 2006 Jun; 29(6):433-41. PubMed ID: 16940706
[TBL] [Abstract][Full Text] [Related]
29. Effect of nasal continuous positive airway pressure treatment on plasma adrenomedullin levels in patients with obstructive sleep apnea syndrome: roles of nocturnal hypoxia and oxidant stress.
Yamamoto H; Teramoto S; Yamaguchi Y; Ouchi Y
Hypertens Res; 2007 Nov; 30(11):1065-76. PubMed ID: 18250556
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular complications of obstructive sleep apnea syndrome: evidence from children.
Bhattacharjee R; Kheirandish-Gozal L; Pillar G; Gozal D
Prog Cardiovasc Dis; 2009; 51(5):416-33. PubMed ID: 19249448
[TBL] [Abstract][Full Text] [Related]
31. Visceral Obesity Mediates the Association Between Metabolic Syndrome and Obstructive Sleep Apnea Syndrome.
Bozkurt NC; Beysel S; Karbek B; Unsal İO; Cakir E; Delibasi T
Metab Syndr Relat Disord; 2016 May; 14(4):217-21. PubMed ID: 27003688
[TBL] [Abstract][Full Text] [Related]
32. Obstructive sleep apnea and hypertension: epidemiology, mechanisms and treatment effects.
Phillips CL; Cistulli PA
Minerva Med; 2006 Aug; 97(4):299-312. PubMed ID: 17008835
[TBL] [Abstract][Full Text] [Related]
33. Obstructive sleep apnea syndrome and asthma: the role of continuous positive airway pressure treatment.
Alkhalil M; Schulman ES; Getsy J
Ann Allergy Asthma Immunol; 2008 Oct; 101(4):350-7. PubMed ID: 18939721
[TBL] [Abstract][Full Text] [Related]
34. NT-pro-BNP in obstructive sleep apnea syndrome is decreased by nasal continuous positive airway pressure.
Tasci S; Manka R; Scholtyssek S; Lentini S; Troatz C; Stoffel-Wagner B; Lüderitz B
Clin Res Cardiol; 2006 Jan; 95(1):23-30. PubMed ID: 16598442
[TBL] [Abstract][Full Text] [Related]
35. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions.
Pack AI; Gislason T
Prog Cardiovasc Dis; 2009; 51(5):434-51. PubMed ID: 19249449
[TBL] [Abstract][Full Text] [Related]
36. [Cardiovascular consequences of obstructive sleep apnoea syndrome].
Kohler M; Russi EW; Bloch KE
Praxis (Bern 1994); 2010 Jan; 99(2):117-22. PubMed ID: 20087831
[TBL] [Abstract][Full Text] [Related]
37. [Surviving sleep: when the heart and brain are damaged by apnea].
Lévy P; Tamisier R; Launois S; Pépin JL
Bull Acad Natl Med; 2011 Oct; 195(7):1611-28; discussion 1628-34. PubMed ID: 22812164
[TBL] [Abstract][Full Text] [Related]
38. Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.
Nobili V; Cutrera R; Liccardo D; Pavone M; Devito R; Giorgio V; Verrillo E; Baviera G; Musso G
Am J Respir Crit Care Med; 2014 Jan; 189(1):66-76. PubMed ID: 24256086
[TBL] [Abstract][Full Text] [Related]
39. Sleep apnea syndrome in endocrine clinics.
Ceccato F; Bernkopf E; Scaroni C
J Endocrinol Invest; 2015 Aug; 38(8):827-34. PubMed ID: 26122486
[TBL] [Abstract][Full Text] [Related]
40. Inflammation accelerates atherosclerotic processes in obstructive sleep apnea syndrome (OSAS).
Quercioli A; Mach F; Montecucco F
Sleep Breath; 2010 Sep; 14(3):261-9. PubMed ID: 20198512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
